FDA Approves New Treatment for HR+, HER2+ Advanced Breast Cancer Following Promising Results from the PATINA Trial by Alliance Foundation
In a landmark advancement for the treatment of advanced breast cancer, the U.S. Food and Drug Administration (FDA) has granted ...
